市場調査レポート

商品コード

1303867

臭汗症疾患治療市場：治療法別（ボトックス、脂肪吸引、手術）、適応症別（紅色陰癬、間擦疹、腋窩白癬）-世界予測2023-2030年

Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: 2023年06月12日 | 発行: 360iResearch

| ページ情報: 英文 182 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF, Excel & Online Access - 1 Year (Single User License)

USD 4,749 744,453円

レポートPDF及びExcelを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Up to 5 User License)

USD 5,749 901,213円

レポートPDF及びExcelを5名まで共有ご利用頂けるライセンスです。ご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Site License)

USD 6,749 1,057,973円

レポートPDF及びExcelを同一事業所（所在地）内のすべての方でご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

PDF, Excel & Online Access - 1 Year (Enterprise User License)

USD 8,749 1,371,493円

レポートPDF及びExcelを同一企業の全世界の方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。購入後1年間、レポートにオンラインでアクセス可能です。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

臭汗症疾患治療の世界市場は、2023年にCAGR 9.32%で4億4,867万米ドル、2030年には8億4,104万米ドルに達すると予測され、大きな成長が見込まれています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の臭汗症疾患治療市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.臭汗症疾患治療の世界市場規模および予測は？

2.予測期間中、世界の臭汗症疾患治療市場を形成するCOVID-19の阻害要因と影響は？

3.臭汗症疾患治療の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.臭汗症疾患治療の世界市場における競争戦略は？

5.臭汗症疾患治療の世界市場における技術動向と規制の枠組みは？

6.臭汗症疾患治療の世界市場における主要ベンダーの市場シェアは？

7.臭汗症疾患治療の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

市場力学
- 促進要因
  - 臭汗症、腎臓疾患、肝臓疾患の増加
  - 臨床試験および研究開発活動への投資の増加
  - 体臭問題に対する意識
- 抑制要因
  - 高額な治療費
- 機会
  - 治療製品の規制当局別承認の急速な増加
  - 腋窩多汗症および臭汗症に対するマイクロ波ベースの治療法の採用
- 課題
  - 製品リコールと健康への悪影響
市場動向
COVID-19の累積的な影響
ロシア・ウクライナ紛争の累積的影響
高インフレの累積的影響
ポーターのファイブフォース分析
バリューチェーンとクリティカルパス分析
規制の枠組み
顧客のカスタマイズ

第6章臭汗症疾患治療市場治療別

ボトックス
脂肪吸引
手術

第7章臭汗症疾患治療市場適応症別

紅斑
間奏
腋窩白癬菌症
2型糖尿病

第8章南北アメリカの臭汗症疾患治療市場

アルゼンチン
ブラジル
カナダ
メキシコ
米国

第9章アジア太平洋地域の臭汗症疾患治療市場

オーストラリア
中国
インド
インドネシア
日本
マレーシア
フィリピン
シンガポール
韓国
台湾
タイ
ベトナム

第10章欧州・中東・アフリカの臭汗症疾患治療市場

デンマーク
エジプト
フィンランド
フランス
ドイツ
イスラエル
イタリア
オランダ
ナイジェリア
ノルウェー
ポーランド
カタール
ロシア
サウジアラビア
南アフリカ
スペイン
スウェーデン
スイス
トルコ
アラブ首長国連邦
英国

第11章競合情勢

FPNVポジショニングマトリクス
市場シェア分析：主要企業別
競合シナリオ分析：主要企業別

第12章掲載企業一覧

第13章付録

ディスカッションガイド
ライセンスと価格について

図表

LIST OF FIGURES

FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 5. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2030 (%)
FIGURE 6. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 7. BROMHIDROSIS DISEASE TREATMENT MARKET DYNAMICS
FIGURE 8. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 15. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 5. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTOX, BY REGION, 2018-2030 (USD MILLION)
TABLE 6. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ERYTHRASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTERTRIGO, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TRICHOMYCOSIS AXILLARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 100. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. BROMHIDROSIS DISEASE TREATMENT MARKET LICENSE & PRICING

Product Code: MRR-742BD517C25D

The Global Bromhidrosis Disease Treatment Market is forecasted to grow significantly, with a projected USD 448.67 million in 2023 at a CAGR of 9.32% and expected to reach a staggering USD 841.04 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bromhidrosis Disease Treatment Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bromhidrosis Disease Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Treatment, market is studied across Botox, Liposuction, and Surgery. The Surgery is projected to witness significant market share during forecast period.

Based on Indication, market is studied across Erythrasma, Intertrigo, Trichomycosis Axillaries, and Type 2 Diabetes. The Intertrigo is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bromhidrosis Disease Treatment Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bromhidrosis Disease Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bromhidrosis Disease Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bromhidrosis Disease Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Bromhidrosis Disease Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Bromhidrosis Disease Treatment Market?

6. What is the market share of the leading vendors in the Global Bromhidrosis Disease Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Bromhidrosis Disease Treatment Market?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bromhidrosis Disease Treatment Market, by Treatment, 2022 vs 2030
4.3. Bromhidrosis Disease Treatment Market, by Indication, 2022 vs 2030
4.4. Bromhidrosis Disease Treatment Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing cases of bromhidrosis and kidney and liver diseases
  - 5.1.1.2. Rising investments in the clinical trials and R&D activities
  - 5.1.1.3. Awareness about body odor issues
- 5.1.2. Restraints
  - 5.1.2.1. High cost of treatment
- 5.1.3. Opportunities
  - 5.1.3.1. Rapid proliferation of regulatory approvals of treatment products
  - 5.1.3.2. Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
- 5.1.4. Challenges
  - 5.1.4.1. Product recalls and adverse health effects
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Bromhidrosis Disease Treatment Market, by Treatment

6.1. Introduction
6.2. Botox
6.3. Liposuction
6.4. Surgery

7. Bromhidrosis Disease Treatment Market, by Indication

7.1. Introduction
7.2. Erythrasma
7.3. Intertrigo
7.4. Trichomycosis Axillaries
7.5. Type 2 Diabetes

8. Americas Bromhidrosis Disease Treatment Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bromhidrosis Disease Treatment Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

臭汗症疾患治療市場：治療法別（ボトックス、脂肪吸引、手術）、適応症別（紅色陰癬、間擦疹、腋窩白癬）-世界予測2023-2030年

Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章臭汗症疾患治療市場治療別

第7章臭汗症疾患治療市場適応症別

第8章南北アメリカの臭汗症疾患治療市場

第9章アジア太平洋地域の臭汗症疾患治療市場

第10章欧州・中東・アフリカの臭汗症疾患治療市場

第11章競合情勢

第12章掲載企業一覧

第13章付録

LIST OF FIGURES

LIST OF TABLES

Market Segmentation & Coverage:

This research report categorizes the Global Bromhidrosis Disease Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Bromhidrosis Disease Treatment Market, by Treatment

7. Bromhidrosis Disease Treatment Market, by Indication

8. Americas Bromhidrosis Disease Treatment Market

9. Asia-Pacific Bromhidrosis Disease Treatment Market

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

11. Competitive Landscape

12. List of Company Mentioned

13. Appendix

臭汗症疾患治療市場：治療法別（ボトックス、脂肪吸引、手術）、適応症別（紅色陰癬、間擦疹、腋窩白癬）-世界予測2023-2030年

Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

FPNVポジショニング・マトリックス

市場シェア分析

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

第6章 臭汗症疾患治療市場治療別

第7章 臭汗症疾患治療市場適応症別

第8章 南北アメリカの臭汗症疾患治療市場

第9章 アジア太平洋地域の臭汗症疾患治療市場

第10章 欧州・中東・アフリカの臭汗症疾患治療市場

第11章 競合情勢

第12章 掲載企業一覧

第13章 付録

LIST OF FIGURES

LIST OF TABLES

Market Segmentation & Coverage:

This research report categorizes the Global Bromhidrosis Disease Treatment Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Market Statistics:

FPNV Positioning Matrix:

Market Share Analysis:

Table of Contents

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

6. Bromhidrosis Disease Treatment Market, by Treatment

7. Bromhidrosis Disease Treatment Market, by Indication

8. Americas Bromhidrosis Disease Treatment Market

9. Asia-Pacific Bromhidrosis Disease Treatment Market

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

11. Competitive Landscape

12. List of Company Mentioned

13. Appendix

第1章序文

第2章調査手法

第3章エグゼクティブサマリー

第4章市場の概要

第5章市場洞察

第6章臭汗症疾患治療市場治療別

第7章臭汗症疾患治療市場適応症別

第8章南北アメリカの臭汗症疾患治療市場

第9章アジア太平洋地域の臭汗症疾患治療市場

第10章欧州・中東・アフリカの臭汗症疾患治療市場

第11章競合情勢

第12章掲載企業一覧

第13章付録